Our flow cytometry and immunofluorescence analyses demonstrated that membrane-bound NCL expression in breast cancer cells (MCF-7 and MDA-MB-468) was significantly higher than in normal cells (** p < 0.01, Figure 8), whereas normal cells (e.g., LX-2) showed negligible membrane NCL levels. This evidence concerns the gene NUCLEOLIN and breast carcinoma.